Process for producing muscarine receptor antagonist

The industrial production of 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutanamide, a urinary incontinence remedy, necessitates elimination of problems concerning the use of a synthetic adsorbent, e.g., HP-20, the efficiency of operation with the same, purification efficiency, etc. An acid salt, e.g., hy...

Full description

Saved in:
Bibliographic Details
Main Authors AONO, MASAHIRO, ISHIGURO, YUUJI, AIZAWA, YASUHIRO
Format Patent
LanguageEnglish
French
German
Published 17.10.2007
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The industrial production of 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutanamide, a urinary incontinence remedy, necessitates elimination of problems concerning the use of a synthetic adsorbent, e.g., HP-20, the efficiency of operation with the same, purification efficiency, etc. An acid salt, e.g., hydrochloride or phosphate, of 4-(2-methyl-1-imidazolyl)-2,2- diphenylbutanamide or a hydrate of any of these salts is used as an intermediate. This intermediate is neutralized and then purified. Thus, high-purity 4-(2-methyl -1-imidazolyl)-2,2-diphenylbutanamide is easily obtained in satisfactory yield. The industrial-scale production process has been thus established.
AbstractList The industrial production of 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutanamide, a urinary incontinence remedy, necessitates elimination of problems concerning the use of a synthetic adsorbent, e.g., HP-20, the efficiency of operation with the same, purification efficiency, etc. An acid salt, e.g., hydrochloride or phosphate, of 4-(2-methyl-1-imidazolyl)-2,2- diphenylbutanamide or a hydrate of any of these salts is used as an intermediate. This intermediate is neutralized and then purified. Thus, high-purity 4-(2-methyl -1-imidazolyl)-2,2-diphenylbutanamide is easily obtained in satisfactory yield. The industrial-scale production process has been thus established.
Author AIZAWA, YASUHIRO
ISHIGURO, YUUJI
AONO, MASAHIRO
Author_xml – fullname: AONO, MASAHIRO
– fullname: ISHIGURO, YUUJI
– fullname: AIZAWA, YASUHIRO
BookMark eNrjYmDJy89L5WQwDijKT04tLlZIyy9SKCjKTylNzsxLV8gtLU5OLMrMS1UoSk1OLSgBSibmlSSm5-dlFpfwMLCmJeYUp_JCaW4GBTfXEGcP3dSC_PjU4oLE5NS81JJ41wBDCxNTA0tDR0NjIpQAAOOpLmw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate Verfahren zur Herstellung eines Antagonisten des Muskarinrezeptors
Procédé de production d'un antagoniste du recepteur de la muscarine
ExternalDocumentID EP1845091A1
GroupedDBID EVB
ID FETCH-epo_espacenet_EP1845091A13
IEDL.DBID EVB
IngestDate Fri Jul 19 15:37:21 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP1845091A13
Notes Application Number: EP20050816720
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20071017&DB=EPODOC&CC=EP&NR=1845091A1
ParticipantIDs epo_espacenet_EP1845091A1
PublicationCentury 2000
PublicationDate 20071017
PublicationDateYYYYMMDD 2007-10-17
PublicationDate_xml – month: 10
  year: 2007
  text: 20071017
  day: 17
PublicationDecade 2000
PublicationYear 2007
RelatedCompanies KYORIN PHARMACEUTICAL CO., LTD
RelatedCompanies_xml – name: KYORIN PHARMACEUTICAL CO., LTD
Score 2.6795287
Snippet The industrial production of 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutanamide, a urinary incontinence remedy, necessitates elimination of problems concerning...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Process for producing muscarine receptor antagonist
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20071017&DB=EPODOC&locale=&CC=EP&NR=1845091A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LSwMxEB5KFfWmVbG-yEH2FlxJ3MehFLsPitB2kSq9lSYm0oO7i7vFv99J2K1e9BYSyGPI5JtJZr4A3KFVi3vX9anWXFLO3j0aMKmpxxELhUTE1sZRnEy98St_XjwuOrBuc2EsT-i3JUdEjZKo77U9r8ufS6zYxlZW92KNVcUwnQ9ip_WOfbPDnHg0SLJZPIucKMKSM31BJecGGp_QUdozVrSh2U_eRiYppfyNKOkx7GfYWV6fQEflPTiM2o_XenAwad67sdioXnUKrAnpJ2hlktLytCLqkM9NJVcmg4_g0aVK9KAJymr1URhG3DMgaTKPxhRHX-5Wukyy3TzZOXTzIlcXQFyp_TAwLCwBWjciDDhTrnqwL4ShJ8I-9P_s5vKftis4sjeVJj7Dv4Zu_bVRNwixtbi1wtkCaaZ_ew
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV07T8MwED5VBdFuUECUpweULSIoJo-hQjQPBWjSCAXULWqMgzqQRE0q_j5nKykssFm25MfJ5-_OvvsMcI1WLe5dzVTznDKV6u-GauksVw2KWJgxROxcOIphZASv9Glxt-jBqsuFkTyhX5IcETWKob438ryufi6xXBlbWd9kK6wq7_1k4iqdd2yKHaa404kXz925ozgOlpToBZWcCmh8QEdpxxTkvMJyepuKpJTqN6L4-7AbY2dFcwA9Xoxg4HQfr41gL2zfu7HYql59CHob0k_QyiSV5GlF1CGfm5otRQYfwaOLV-hBE5TV8qMUjLhHQHwvcQIVR0-3K029eDtP_Rj6RVnwEyAay03bEiwsFlo3mW1RnWv8Vr4Q2kZmj2H8Zzen_7RdwSBIwlk6e4yez2Aoby1FrIZ5Dv1mveEXCLdNdikF9Q2IGIJo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Process+for+producing+muscarine+receptor+antagonist&rft.inventor=AONO%2C+MASAHIRO&rft.inventor=ISHIGURO%2C+YUUJI&rft.inventor=AIZAWA%2C+YASUHIRO&rft.date=2007-10-17&rft.externalDBID=A1&rft.externalDocID=EP1845091A1